AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Udigiv 300mg Tablet

Prescription Icon
Prescription Required

Marketer

Anglo-French Drugs & Industries Ltd

Salt Composition

Ursodeoxycholic Acid (300mg)

Overview Udigiv 300mg Tablet

Gallstone dissolution and prevention are key applications of Ursodeoxycholic Acid 300mg tablets (e.g., Udigiv). This medication also treats primary biliary cirrhosis, a liver ailment, by metabolizing cholesterol-based gallstones. Administer the tablet whole post-prandially with water or milk. Dosage is individualized based on condition and weight. Consistent use, as directed (potentially months or longer), is crucial, even if symptoms abate. Common, but not universal, side effects include abdominal discomfort, diarrhea, alopecia, pruritus, nausea, and skin rashes. Report persistent or concerning side effects to your physician. Prior to commencing therapy, disclose any history of gallbladder or bile duct inflammation, recurrent upper abdominal cramping, hemoptysis, or rapid weight gain. Inform your doctor of all concurrent medications, as interactions are possible (including increased or decreased efficacy). Women should cease hormonal contraception due to potential gallstone formation exacerbation. Regular ultrasound examinations and liver function blood tests may be required throughout treatment.

Uses of Udigiv 300mg Tablet

Managing primary biliary cholangitis | Addressing cholelithiasis

Major Benefits of Udigiv 300mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 300mg Udigiv tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Udigiv 300mg Tablet:

  • Abdominal pain
  • Diarrhea
  • Hair loss
  • Itching
  • Nausea
  • Rash

How to use Udigiv 300mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the 300mg Udigiv tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Udigiv 300mg Tablet works:

HepatoGuard 300mg tablets offer liver protection by lowering blood cholesterol levels and aiding in the dissolution of cholesterol-based gallstones. This medication also enhances liver enzyme function, safeguards liver cells against bile acid toxicity, and promotes overall liver health.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Taking Udigiv 300mg tablets with alcohol can lead to significant sleepiness.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Udigiv 300mg tablets is generally deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; however, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of Udigiv 300mg tablets appear compatible. Available human data indicate minimal risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Udigiv 300mg Tablets.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Udigiv 300mg Tablet use in individuals with impaired kidney function is scarce. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the use of Udigiv 300mg Tablet in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Udigiv 300mg Tablet :

Omit any missed Udigiv 300mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.

Facts to Know About Udigiv 300mg Tablet

LabelValue
Type of Compound Gallbladder Acids and Salts
Potential for Dependence None.
Type of Medication Stomach and intestinal
Mechanism of Action Liver protectants

FAQs on Udigiv 300mg Tablet

Dosage frequency for this medication varies according to individual needs. Your physician may prescribe two to three daily doses, with the final dose administered before sleep. Udigiv 300mg Tablets should be swallowed with water or milk and may be taken with or without food. For gallstone dissolution, a single nightly dose is typically recommended. To maintain optimal spacing, doses should ideally be separated by six hours—for instance, at 8 AM, 2 PM, and 8 PM.
Gallstone patients may find the 300mg Udigiv Tablet a safe and efficacious treatment alternative to surgery. While generally well-tolerated, diarrhea is a possible side effect. Should diarrhea develop, dosage adjustment or treatment cessation may be necessary depending on severity. Prolonged use can potentially impact liver enzyme levels, necessitating regular monitoring by your physician. These potential drawbacks notwithstanding, the medication offers a viable non-surgical option for suitable candidates.
Udigiv 300mg tablets target the liver, accumulating in the bile it produces. This action inhibits cholesterol production and release from the liver, lowering cholesterol levels within the bile. The medication further restricts intestinal absorption of bile salts and cholesterol. Consequently, decreased cholesterol saturation in hepatic bile promotes gradual gallstone dissolution, shrinking them and ultimately resolving them. Increased bile flow through the liver also lowers elevated liver enzyme levels, safeguarding liver cells.
Weight gain is a possible, though infrequent, side effect of Udigiv 300mg Tablet. This side effect is more likely in individuals with liver disease involving chronic bile stasis within the liver's small bile ducts, hindering bile flow to the intestines. However, the likelihood of weight gain varies; therefore, any weight changes should be discussed with your physician.
Concurrent use of Udigiv 300mg tablets with antacids should be discussed with your physician, as antacids can diminish Udigiv 300mg's efficacy. Similarly, the simultaneous administration of cholestyramine or colestipol may also reduce Udigiv 300mg's effectiveness; consult your doctor regarding appropriate dosing intervals. Furthermore, concomitant use of oral contraceptives, estrogenic hormones, and cholesterol-reducing drugs like clofibrate should be avoided due to their potential to increase gallstone risk and counteract the therapeutic effects of Udigiv 300mg.
Udigiv 300mg Tablet
350
MRP 426
17% off